Clinical & translational oncology

• 

  Año 2020, Vol. 22, Número 9

  • Review Article

    • Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine

      Jordi Remón Masip, F. Tabbò, Begoña Jiménez, Ana Collazo Lorduy, Javier de Castro Carpeño, S. Novello

      • Resumen

      págs. 1425-1429

      

    • Genomic profiling in oncology clinical practice

      Núria Rodríguez de Dios, David Viñal, J. Rodríguez Cobos, Javier de Castro Carpeño, Gemma Domínguez Muñoz

      • Resumen

      págs. 1430-1439

      

    • Precision medicine in Ewing sarcoma: a translational point of view

      P. Gargallo, A. Juan Ribelles, Y. Yáñez, Sandra Dolz Giménez, Vanessa Segura, Victoria Castel Sánchez, María Adela Cañete Nieto

      • Resumen

      págs. 1440-1454

      

  • Research Article

    • Treatment patterns for metastatic colorectal cancer in Spain

      Enrique Aranda Aguilar, Eduardo Polo Marqués, Carlos Camps Herrero, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, Vicente Guillem Porta, R. López, A. Antón Torres

      • Resumen

      págs. 1455-1462

      

    • Gm6377 suppressed SP 2/0 xenograft tumor by down‑regulating Myc transcription

      B. Zhai, C. Hou, R. Xu, Y. Fang, M. Ma, C. Xing, X. Wang, H. Xiao, G. Chen, G. Han, R. Wang

      • Resumen

      págs. 1463-1471

      

    • DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome

      S. Kashyap, J. Jha, M.K. Singh, L. Singh, S. Sen, J. Kaur, M. S. Bajaj, N. Pushker

      • Resumen

      págs. 1472-1480

      

    • Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer

      A. Iglesias Santamaría

      • Resumen

      págs. 1481-1490

      

    • Regorafenib and ginsenoside combination therapy: inhibition of HepG2 cell growth through modulating survivin and caspase‑3 gene expression

      B. Wang, F. Wang, A. Ding, H. Zhao, X. Bu

      • Resumen

      págs. 1491-1498

      

    • A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer

      X. Chen Zhao, Ovidio Hernando Requejo, M. López, E. Sánchez, Angel Montero, Mariola García Aranda, Raquel Ciérvide Jurío, J. Valero Gasalla, R. Alonso, J.M. Cárdenas Rebollo, E. Vicente, Yolanda Quijano, A. Cubillo, R. Álvarez, S. Prados, C. Plaza, J. García, D. Zucca Aparicio, Pedro Fernández Letón, C. Rubio

      • Resumen

      págs. 1499-1505

      

    • RNF213 suppresses carcinogenesis in glioblastoma by affecting MAPK/ JNK signaling pathway

      X. Wang, M. Ye, M. Wu, H. Fang, B. Jiao, L. Xie, X. Zhu

      • Resumen

      págs. 1506-1516

      

    • Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma

      J. F.M. José, M. Jose, R. Silverio, V. Federico, C. Isabel, O.A. Martin, B. Inmaculada, C. Cristina, H.C. Julia, T.M. Dolores, G. Jose, P. Paola, Del P. Nieves, A. Vicent, B. Sara, M. Sara, L. Julián, S. Manuel, M.M. del Carmen, C.M. Ángel, G. Vicente

      • Resumen

      págs. 1517-1523

      

    • The lncRNA Fer1L4 is an adverse prognostic parameter in clear‑cell renal‑cell carcinoma

      A. Cox, Y. Tolkach, G. Kristiansen, M. Ritter, J. Ellinger

      • Resumen

      págs. 1524-1531

      

    • Hypofractionated volumetric modulated arc therapy (VMAT) for fragile patients with oesophageal cancer

      Letizia Deantonio, Simona Cima, Stefano Leva, Antonella Richetti, Mariacarla Valli

      • Resumen

      págs. 1532-1538

      

    • Cyclooxygenase‑2 expression as a prognostic factor in pediatric classical Hodgkin lymphoma

      Y. Elborai, A. Elgammal, Ahmed A. K. Salama, M. Fawzy, E. D. El Desouky, I. Attia, L.M. Shalaby

      • Resumen

      págs. 1539-1547

      

    • Prognostic and predictive values of CXCL10 in colorectal cancer

      J. Chen, Q.L. Chen, W.-H. Wang, X.L. Chen, X.Q. Hu, Z.Q. Liang, Y.. Cao, Y.M. Cao, S.B. Su

      • Resumen

      págs. 1548-1564

      

    • A new scenario in metastatic renal cell carcinoma: a SOG‑GU consensus

      Sergio Vázquez Estévez, Urbano Anido Herranz, Martin Lázaro Quintela, Ovidio Fernández Calvo, N. Fernández Núñez, N. de Dios Álvarez, Silvia Varela Ferreiro, Begoña Campos Balea, Sara Agraso Busto, María Carmen Areses Manrique, Lara Iglesias Docampo, M. Blanco, S. Maciá Escalante, Luis Antón Aparicio

      • Resumen

      págs. 1565-1579

      

    • The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta‑analysis

      Y. Shuai, X. Zhou, C. Li

      • Resumen

      págs. 1580-1590

      

    • DT‑13 inhibits breast cancer cell migration via non‑muscle myosin II‑A regulation in tumor microenvironment synchronized adaptation

      Y. Gao, G.J. Khan, X. Wei, K.F. Zhai, L. Sun, S. Yuan

      • Resumen

      págs. 1591-1602

      

    • Resistin is associated with overall survival in non‑small cell lung cancer patients during nivolumab treatment

      A. Bonaventura, F. Grossi, F. Carbone, A. Vecchié, S. Minetti, N. Bardi, E. Elia, A.M. Ansaldo, D. Ferrara, E. Rijavec, M.G. Dal Bello, G. Rossi, F. Biello, M. Tagliamento, A. Alama, S. Coco, P. Spallarossa, F. Dallegri, C. Genova, F. Montecucco

      • Resumen

      págs. 1603-1610

      

    • Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21‑years prospective study from a single institution

      José Antonio Avilés Izquierdo, Lula María Nieto Benito, Pablo Lázaro Ochaíta, José Luis Escat Cortés, Iván Márquez Rodas, Enrique Mercader Cidoncha

      • Resumen

      págs. 1611-1618

      

    • Suppressive role of Viola odorata extract on malignant characters of mammosphere‑derived breast cancer stem cells

      S. Yousefnia, H. F. Yaseri, F. Seyed Forootan, M. Tabatabaeian, F. Moattar, T. Ghafghazi, M.H. Nasr Esfahani, K. Ghaedi

      • Resumen

      págs. 1619-1634

      

    • Impact of pre‑radiation therapy quality of life in lung cancer survival: a prospective, intention‑to‑treat, multicenter study

      J. M. Nieto-Guerrero Gómez, G.P. Silva Vega, Jon Cacicedo Fernández de Bobadilla, D. Delgado, D. Herrero Rivera, JM Praena-Fernández, Eleonor Rivín del Campo, María José Ortiz Gordillo, José Luis López Guerra

      • Resumen

      págs. 1635-1644

      

  • Brief Research Article

    • Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population‑based study

      O. Abdel Rahman

      • Resumen

      págs. 1645-1650

      

    • Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials

      Omar Mohammed Abdel-Rahman, S. Ghosh, J. Walker

      • Resumen

      págs. 1651-1656

      

    • Immunotherapy‑based combinations versus standard first‑line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta‑analysis

      Sebastiano Buti, Fausto Petrelli, Antonio Ghidini, Ivano Vavassori, Umberto Maestroni, Melissa Bersanelli

      • Resumen

      págs. 1657-1663

      

  • Correspondence

    • Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk

      G. Roviello, D. Villari, R. Roud

      págs. 1664-1665